title: [The use of direct oral anticoagulants (DOAC) in the treatment atrial fibrillation (AF) patients].
abstract: AF is associated with the risk of stroke, and this risk is exceedingly high in elderly patients (> or = 75 years) and in patients after a stroke. DOACs are appropriate anticoagulants for AF patients without mechanical heart valves or mitral stenosis. Patients on DOACs do not require routine monitoring of coagulation, but need regular follow-up visits including an assessment of therapy adherence, thromboembolic and bleeding events and measurements of hemoglobin and platelets values as well as renal and liver function.
authors.forename: Mika
authors.initials: M
authors.lastname: Lehto
authors.forename: Pirjo
authors.initials: P
authors.lastname: Mustonen
authors.forename: Ilkka
authors.initials: I
authors.lastname: Tierala
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007677:Kidney Function Tests; D008111:Liver Function Tests; D055118:Medication Adherence; D010976:Platelet Count; D012306:Risk; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D006454:Hemoglobins